# This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer.

> **NCT07309887** · — · NOT_YET_RECRUITING · sponsor: **Samsung Medical Center** · enrollment: 100000 (estimated)

## Conditions studied

- Early Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07309887
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-17
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100000 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07309887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07309887, "This Clinical Trial is a Retrospective, Multicenter Cohort Study Evaluating the Real-world Characteristics and Risk of Disease Recurrence in Hormone Receptor-positive, HER2-negative Early Breast Cancer.". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT07309887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*